| James C Matthews Iii, DO | |
|
1800 12th St, Meridian, MS 39301-4158 | |
| (601) 703-9265 | |
| (601) 703-9936 |
| Full Name | James C Matthews Iii |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 1800 12th St, Meridian, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164417598 | NPI | - | NPPES |
| 00116777 | Medicaid | MS | |
| 080084092 | Other | RAIL ROAD MEDICARE | |
| 009607830 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 14769 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sta Home Health And Hospice | Carthage, MS | Home health agency |
| Amedisys Home Health | Meridian, MS | Home health agency |
| Kindred At Home | Meridian, MS | Home health agency |
| Rush Foundation Hospital | Meridian, MS | Hospital |
| H C Watkins Memorial Hospital Inc | Quitman, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush Medical Foundation | 2567368541 | 26 |
| Medical Foundation Inc | 9234043712 | 125 |
News Archive
Follow-up data on patients with degenerative disease of the upper (cervical) spinal vertebrae show little or no evidence of worsening degeneration over time, according to a study in the February 15 issue of Spine.
CVS Caremark Corporation today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
Researchers from University of Virginia School of Medicine have uncovered the mystery behind development of allergic reactions to red meat such as beef in some individuals. Recently there has been a body of research on allergies to meat developing in individuals due to tick bites.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Bill Gates, co-chair of the foundation, discusses his annual letter, which will be sent on January 30, according to the blog.
› Verified 7 days ago
| Entity Name | Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609820539 PECOS PAC ID: 9234043712 Enrollment ID: O20031118000855 |
News Archive
Follow-up data on patients with degenerative disease of the upper (cervical) spinal vertebrae show little or no evidence of worsening degeneration over time, according to a study in the February 15 issue of Spine.
CVS Caremark Corporation today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
Researchers from University of Virginia School of Medicine have uncovered the mystery behind development of allergic reactions to red meat such as beef in some individuals. Recently there has been a body of research on allergies to meat developing in individuals due to tick bites.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Bill Gates, co-chair of the foundation, discusses his annual letter, which will be sent on January 30, according to the blog.
› Verified 7 days ago
| Entity Name | Rush Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588625594 PECOS PAC ID: 2567368541 Enrollment ID: O20031210000541 |
News Archive
Follow-up data on patients with degenerative disease of the upper (cervical) spinal vertebrae show little or no evidence of worsening degeneration over time, according to a study in the February 15 issue of Spine.
CVS Caremark Corporation today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
Researchers from University of Virginia School of Medicine have uncovered the mystery behind development of allergic reactions to red meat such as beef in some individuals. Recently there has been a body of research on allergies to meat developing in individuals due to tick bites.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Bill Gates, co-chair of the foundation, discusses his annual letter, which will be sent on January 30, according to the blog.
› Verified 7 days ago
| Entity Name | Rush Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467736421 PECOS PAC ID: 6901702901 Enrollment ID: O20031210000862 |
News Archive
Follow-up data on patients with degenerative disease of the upper (cervical) spinal vertebrae show little or no evidence of worsening degeneration over time, according to a study in the February 15 issue of Spine.
CVS Caremark Corporation today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
Researchers from University of Virginia School of Medicine have uncovered the mystery behind development of allergic reactions to red meat such as beef in some individuals. Recently there has been a body of research on allergies to meat developing in individuals due to tick bites.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Bill Gates, co-chair of the foundation, discusses his annual letter, which will be sent on January 30, according to the blog.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James C Matthews Iii, DO 1800 12th St, Meridian, MS 39301-4158 Ph: (601) 703-4282 | James C Matthews Iii, DO 1800 12th St, Meridian, MS 39301-4158 Ph: (601) 703-9265 |
News Archive
Follow-up data on patients with degenerative disease of the upper (cervical) spinal vertebrae show little or no evidence of worsening degeneration over time, according to a study in the February 15 issue of Spine.
CVS Caremark Corporation today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
Researchers from University of Virginia School of Medicine have uncovered the mystery behind development of allergic reactions to red meat such as beef in some individuals. Recently there has been a body of research on allergies to meat developing in individuals due to tick bites.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Bill Gates, co-chair of the foundation, discusses his annual letter, which will be sent on January 30, according to the blog.
› Verified 7 days ago
Dr. Shawn C Anderson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2024 15th St Fl 2, Meridian, MS 39301 Phone: 601-553-2000 Fax: 601-553-6873 | |
Dr. Chadley T Vega, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2124 14th St, Meridian, MS 39301 Phone: 601-553-6000 | |
Dr. Marshall Scott Tynes, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave, Medical Towers Iii, Meridian, MS 39301 Phone: 601-483-5322 Fax: 601-581-2289 | |
Linda F. Mccullar, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1818 College Drive, Meridian, MS 39307 Phone: 601-581-7600 | |
Dr. Gary G. Gordon, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9265 Fax: 601-703-9401 | |
Dr. William Lee Brown Iv, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 905c S Frontage Rd, Meridian, MS 39301 Phone: 601-482-4955 | |
Kavi Satish Patel, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 905c S Frontage Rd, Meridian, MS 39301 Phone: 601-482-4955 |